Link to Pubmed [PMID] – 35181769
Link to DOI – 10.1038/s41579-022-00708-x
Nat Rev Microbiol 2022 Apr; 20(4): 187-188
The magnitude of immune evasion of Omicron raises the question whether it should be considered as a distinct SARS-CoV-2 serotype. Here, we discuss lines of evidence in support or against the concept of SARS-CoV-2 serotypes, and the implications of this classification.